$IDEV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Endo Pharmaceuticals Solutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Endo Pharmaceuticals Solutions Inc.. Get notifications about new insider transactions in Endo Pharmaceuticals Solutions Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 11 2007 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | EVP and Chief Busin ... | Option Exercise | D | 6.00 | 45,000 | 270,000 | 0 | |
Jan 05 2007 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 6.10 | 78,400 | 478,240 | 56,300 | 134.7 K to 56.3 K (-58.20 %) |
Jan 05 2007 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 6.10 | 1,921,600 | 11,721,760 | 1,380,650 | 3.3 M to 1.4 M (-58.19 %) |
Oct 20 2006 | IDEV | Endo Pharmaceutica ... | FARB THOMAS F | President | Option Exercise | A | 6.32 | 600,000 | 3,792,000 | 600,000 | |
Oct 20 2006 | IDEV | Endo Pharmaceutica ... | FARB THOMAS F | President | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Oct 03 2006 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Grant | A | 5.03 | 398 | 2,002 | 11,141 | 10.7 K to 11.1 K (+3.70 %) |
Jun 29 2006 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.65 | 2,000,000 | 9,300,000 | 3,302,250 | 1.3 M to 3.3 M (+153.58 %) |
Apr 12 2006 | IDEV | Endo Pharmaceutica ... | FERRARA ANDREW J | Director | Option Exercise | A | 5.52 | 50,000 | 276,000 | 50,000 | |
Apr 04 2006 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 2.37 | 870 | 2,062 | 61,183 | 60.3 K to 61.2 K (+1.44 %) |
Apr 04 2006 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Grant | A | 2.37 | 7,258 | 17,201 | 10,743 | 3.5 K to 10.7 K (+208.26 %) |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 6.36 | 15,000 | 95,400 | 15,000 | |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | HANSON MICHAEL E | Director | Option Exercise | A | 6.36 | 15,000 | 95,400 | 15,000 | |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | MORLEY CHERYL P | Director | Option Exercise | A | 6.36 | 15,000 | 95,400 | 15,000 | |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | A | 6.36 | 15,000 | 95,400 | 15,000 | |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | SHARROCK DAVID B | Director | Option Exercise | A | 6.36 | 15,000 | 95,400 | 15,000 | |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | SHARROCK DAVID B | Director | Option Exercise | A | 6.36 | 15,000 | 95,400 | 15,000 | |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 0.00 | 28,800 | 0 | 30,329 | 1.5 K to 30.3 K (+1,883.58 %) |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 0.00 | 28,800 | 0 | 89,113 | 60.3 K to 89.1 K (+47.75 %) |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | EVP and Chief Busin ... | Grant | A | 0.00 | 28,800 | 0 | 31,099 | 2.3 K to 31.1 K (+1,252.72 %) |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Grant | A | 0.00 | 28,800 | 0 | 151,117 | 122.3 K to 151.1 K (+23.55 %) |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | Tucker John H | EVP, Chief Marketin ... | Grant | A | 0.00 | 28,800 | 0 | 35,823 | 7 K to 35.8 K (+410.08 %) |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Grant | A | 0.00 | 71,900 | 0 | 266,900 | 195 K to 266.9 K (+36.87 %) |
Mar 09 2006 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Grant | A | 0.00 | 71,900 | 0 | 266,900 | 195 K to 266.9 K (+36.87 %) |
Feb 21 2006 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | A | 4.06 | 375,000 | 1,523,438 | 375,000 | |
Feb 21 2006 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | D | 4.06 | 375,000 | 1,523,438 | 0 | |
Jan 09 2006 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Buy | P | 5.85 | 10,000 | 58,500 | 195,000 | 185 K to 195 K (+5.41 %) |
Jan 27 2006 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | M | 2.38 | 3,000 | 7,140 | 434,500 | |
Jan 27 2006 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Gift | G | 0.00 | 3,000 | 0 | 60,313 | 63.3 K to 60.3 K (-4.74 %) |
Jan 27 2006 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Buy | M | 2.38 | 3,000 | 7,140 | 63,313 | 60.3 K to 63.3 K (+4.97 %) |
Jan 06 2006 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 5.10 | 2,000 | 10,200 | 1,529 | 3.5 K to 1.5 K (-56.67 %) |
Jan 06 2006 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 5.11 | 3,647 | 18,636 | 3,529 | 7.2 K to 3.5 K (-50.82 %) |
Dec 15 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.96 | 2,000 | 7,920 | 116,900 | 114.9 K to 116.9 K (+1.74 %) |
Dec 15 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.43 | 2,000 | 6,860 | 114,900 | 112.9 K to 114.9 K (+1.77 %) |
Dec 15 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.96 | 18,000 | 71,280 | 1,141,850 | 1.1 M to 1.1 M (+1.60 %) |
Dec 15 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.43 | 18,000 | 61,740 | 1,123,850 | 1.1 M to 1.1 M (+1.63 %) |
Dec 19 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.50 | 2,800 | 12,600 | 134,700 | 131.9 K to 134.7 K (+2.12 %) |
Dec 19 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.18 | 15,000 | 62,700 | 131,900 | 116.9 K to 131.9 K (+12.83 %) |
Dec 19 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.50 | 25,400 | 114,300 | 1,302,250 | 1.3 M to 1.3 M (+1.99 %) |
Dec 19 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.18 | 135,000 | 564,300 | 1,276,850 | 1.1 M to 1.3 M (+11.82 %) |
Dec 02 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.12 | 1,800 | 7,416 | 112,900 | 111.1 K to 112.9 K (+1.62 %) |
Dec 02 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.14 | 2,200 | 9,108 | 111,100 | 108.9 K to 111.1 K (+2.02 %) |
Dec 02 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.12 | 16,200 | 66,744 | 1,105,830 | 1.1 M to 1.1 M (+1.49 %) |
Dec 02 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.14 | 19,800 | 81,972 | 1,089,630 | 1.1 M to 1.1 M (+1.85 %) |
Nov 21 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.08 | 2,000 | 8,160 | 106,900 | 104.9 K to 106.9 K (+1.91 %) |
Nov 21 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.08 | 18,000 | 73,440 | 1,051,830 | 1 M to 1.1 M (+1.74 %) |
Nov 23 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.16 | 2,000 | 8,320 | 108,900 | 106.9 K to 108.9 K (+1.87 %) |
Nov 23 2005 | IDEV | Endo Pharmaceutica ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 4.16 | 18,000 | 74,880 | 1,069,830 | 1.1 M to 1.1 M (+1.71 %) |
Oct 04 2005 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Grant | A | 2.37 | 2,425 | 5,747 | 3,485 | 1.1 K to 3.5 K (+228.77 %) |
Oct 04 2005 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 2.37 | 2,274 | 5,389 | 60,313 | 58 K to 60.3 K (+3.92 %) |
Oct 04 2005 | IDEV | Endo Pharmaceutica ... | Tucker John H | EVP, Chief Marketin ... | Grant | A | 2.37 | 1,363 | 3,230 | 2,351 | 988 to 2.4 K (+137.96 %) |
Apr 04 2005 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.36 | 1,529 | 3,608 | 5,076 | 3.5 K to 5.1 K (+43.11 %) |
Apr 04 2005 | IDEV | Endo Pharmaceutica ... | Tucker John H | EVP, Chief Marketin ... | Grant | A | 2.36 | 4,672 | 11,026 | 5,660 | 988 to 5.7 K (+472.87 %) |
Mar 15 2005 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | M | 2.36 | 1,250 | 2,950 | 2,500 | |
Mar 15 2005 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Grant | A | 2.36 | 1,250 | 2,950 | 22,000 | 20.8 K to 22 K (+6.02 %) |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | SHARROCK DAVID B | Director | Option Exercise | A | 3.70 | 25,000 | 92,500 | 25,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | SHARROCK DAVID B | Director | Option Exercise | A | 3.55 | 15,000 | 53,250 | 15,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | A | 3.55 | 15,000 | 53,250 | 15,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | MORLEY CHERYL P | Director | Option Exercise | A | 3.55 | 15,000 | 53,250 | 15,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | HANSON MICHAEL E | Director | Option Exercise | A | 3.55 | 15,000 | 53,250 | 15,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 3.55 | 15,000 | 53,250 | 15,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | GRAY HARRY J | Director | Option Exercise | A | 3.55 | 15,000 | 53,250 | 15,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 3.70 | 75,000 | 277,500 | 75,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | Tucker John H | EVP, Chief Marketin ... | Option Exercise | A | 3.70 | 25,000 | 92,500 | 25,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 3.70 | 25,000 | 92,500 | 25,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | A | 3.70 | 25,000 | 92,500 | 25,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | EVP and Chief Busin ... | Option Exercise | A | 3.70 | 25,000 | 92,500 | 25,000 | |
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | A | 3.70 | 25,000 | 92,500 | 25,000 | |
Feb 16 2005 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Buy | P | 4.05 | 10,000 | 40,500 | 185,000 | 175 K to 185 K (+5.71 %) |
Feb 04 2005 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | M | 2.38 | 6,500 | 15,438 | 0 | |
Feb 04 2005 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | M | 2.36 | 1,250 | 2,950 | 3,750 | |
Feb 04 2005 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Buy | X | 2.38 | 6,500 | 15,438 | 20,750 | 14.3 K to 20.8 K (+45.61 %) |
Feb 04 2005 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Buy | X | 2.36 | 1,250 | 2,950 | 14,250 | 13 K to 14.3 K (+9.62 %) |
Jan 11 2005 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 1,700 | 4,038 | 369,000 | |
Jan 11 2005 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 3,800 | 9,025 | 370,700 | |
Jan 11 2005 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 5.45 | 1,700 | 9,265 | 3,647 | 5.3 K to 3.6 K (-31.79 %) |
Jan 11 2005 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 1,700 | 4,038 | 7,347 | 5.6 K to 7.3 K (+30.10 %) |
Jan 11 2005 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 5.41 | 3,800 | 20,558 | 3,647 | 7.4 K to 3.6 K (-51.03 %) |
Jan 11 2005 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 3,800 | 9,025 | 9,447 | 5.6 K to 9.4 K (+67.29 %) |
Dec 17 2004 | IDEV | Endo Pharmaceutica ... | HANSON MICHAEL E | Director | Option Exercise | A | 6.65 | 50,000 | 332,500 | 50,000 | |
Dec 03 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 5,500 | 13,063 | 374,500 | |
Dec 03 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 6.87 | 1,500 | 10,305 | 5,647 | 7.1 K to 5.6 K (-20.99 %) |
Dec 03 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 6.87 | 5,500 | 37,785 | 7,147 | 12.6 K to 7.1 K (-43.49 %) |
Dec 03 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 5,500 | 13,063 | 12,647 | 7.1 K to 12.6 K (+76.96 %) |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 12,686 | 30,129 | 402,500 | |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 14,814 | 35,183 | 415,186 | |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 5,000 | 11,875 | 430,000 | |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 6.95 | 12,686 | 88,168 | 7,147 | 19.8 K to 7.1 K (-63.96 %) |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 12,686 | 30,129 | 19,833 | 7.1 K to 19.8 K (+177.50 %) |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 6.92 | 14,814 | 102,513 | 7,147 | 22 K to 7.1 K (-67.46 %) |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 14,814 | 35,183 | 21,961 | 7.1 K to 22 K (+207.28 %) |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 6.79 | 5,000 | 33,950 | 7,147 | 12.1 K to 7.1 K (-41.16 %) |
Oct 19 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 5,000 | 11,875 | 12,147 | 7.1 K to 12.1 K (+69.96 %) |
Oct 28 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 7,500 | 17,813 | 380,000 | |
Oct 28 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 15,000 | 35,625 | 387,500 | |
Oct 28 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 6.92 | 7,500 | 51,900 | 7,147 | 14.6 K to 7.1 K (-51.21 %) |
Oct 28 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 7,500 | 17,813 | 14,647 | 7.1 K to 14.6 K (+104.94 %) |
Oct 28 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 6.44 | 15,000 | 96,600 | 7,147 | 22.1 K to 7.1 K (-67.73 %) |
Oct 28 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 15,000 | 35,625 | 22,147 | 7.1 K to 22.1 K (+209.88 %) |
Oct 06 2004 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | M | 2.38 | 12,000 | 28,500 | 6,500 | |
Oct 06 2004 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Grant | A | 2.38 | 12,000 | 28,500 | 13,000 | 1,000 to 13 K (+1,200.00 %) |
Oct 05 2004 | IDEV | Endo Pharmaceutica ... | SHARROCK DAVID B | Director | Option Exercise | M | 2.38 | 50,000 | 118,750 | 50,000 | |
Oct 05 2004 | IDEV | Endo Pharmaceutica ... | SHARROCK DAVID B | Director | Sell | S | 7.18 | 8,010 | 57,512 | 5,000 | 13 K to 5 K (-61.57 %) |
Oct 05 2004 | IDEV | Endo Pharmaceutica ... | SHARROCK DAVID B | Director | Sell | S | 7.19 | 41,990 | 301,908 | 13,010 | 55 K to 13 K (-76.35 %) |
Oct 05 2004 | IDEV | Endo Pharmaceutica ... | SHARROCK DAVID B | Director | Grant | A | 2.38 | 50,000 | 118,750 | 55,000 | 5 K to 55 K (+1,000.00 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | M | 2.38 | 15,000 | 35,625 | 437,500 | |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | M | 2.38 | 10,000 | 23,750 | 452,500 | |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Sell | S | 7.13 | 15,000 | 106,950 | 58,039 | 73 K to 58 K (-20.54 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 2.38 | 15,000 | 35,625 | 73,039 | 58 K to 73 K (+25.84 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Sell | S | 7.13 | 10,000 | 71,300 | 58,039 | 68 K to 58 K (-14.70 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 2.38 | 10,000 | 23,750 | 68,039 | 58 K to 68 K (+17.23 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Grant | A | 5.19 | 1,041 | 5,398 | 1,060 | 19 to 1.1 K (+5,478.95 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 4,890 | 11,614 | 435,000 | |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 5.19 | 607 | 3,147 | 7,147 | 6.5 K to 7.1 K (+9.28 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 7.00 | 4,890 | 34,230 | 6,540 | 11.4 K to 6.5 K (-42.78 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 4,890 | 11,614 | 11,430 | 6.5 K to 11.4 K (+74.77 %) |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | EVP and Chief Busin ... | Grant | A | 5.19 | 2,299 | 11,920 | 2,299 | 0 to 2.3 K |
Oct 04 2004 | IDEV | Endo Pharmaceutica ... | Tucker John H | EVP, Chief Marketin ... | Grant | A | 5.19 | 988 | 5,123 | 988 | 2 K to 988 (-50.00 %) |
Sep 30 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 20,110 | 47,761 | 439,890 | |
Sep 30 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 25,000 | 59,375 | 460,000 | |
Sep 30 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 2.38 | 20,110 | 47,761 | 6,540 | 26.7 K to 6.5 K (-75.46 %) |
Sep 30 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | X | 2.38 | 20,110 | 47,761 | 26,650 | 46.8 K to 26.7 K (-43.01 %) |
Sep 30 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 6.97 | 25,000 | 174,250 | 6,540 | 31.5 K to 6.5 K (-79.26 %) |
Sep 30 2004 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Buy | X | 2.38 | 25,000 | 59,375 | 31,540 | 6.5 K to 31.5 K (+382.26 %) |
Sep 24 2004 | IDEV | Endo Pharmaceutica ... | Tucker John H | EVP, Chief Marketin ... | Option Exercise | A | 6.93 | 200,000 | 1,386,000 | 200,000 | |
Sep 24 2004 | IDEV | Endo Pharmaceutica ... | Tucker John H | EVP, Chief Marketin ... | Option Exercise | A | 6.93 | 200,000 | 1,386,000 | 200,000 | |
Sep 24 2004 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | EVP and Chief Busin ... | Option Exercise | A | 6.93 | 200,000 | 1,386,000 | 200,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | A | 6.19 | 45,000 | 278,550 | 45,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | D | 6.19 | 45,000 | 278,550 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | A | 3.56 | 45,000 | 160,200 | 45,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | D | 3.56 | 45,000 | 160,200 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 60,000 | 249,600 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 60,000 | 249,600 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 6.19 | 800,000 | 4,952,000 | 800,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 6.19 | 800,000 | 4,952,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 300,000 | 1,248,000 | 300,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 300,000 | 1,248,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 60,000 | 249,600 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 60,000 | 249,600 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 6.19 | 800,000 | 4,952,000 | 800,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 6.19 | 800,000 | 4,952,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 300,000 | 1,248,000 | 300,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 300,000 | 1,248,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 4.16 | 60,000 | 249,600 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 4.16 | 60,000 | 249,600 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 |